Overview
What is Early Diagnosis And Treatment Research Foundation Inc?
Early Diagnosis and Treatment Research Foundation Inc., located in New York, is a dedicated nonprofit organization that prioritizes research in the field of early detection and treatment of various diseases. Primarily focusing on conditions such as lung cancer, chronic obstructive pulmonary diseases, and cardiac diseases, the foundation supports and advances research through continuous, active conduct. By making grants to other institutions, organizing conferences, and conducting studies, they provide valuable insights and foster collaborative efforts in joint research endeavors. The foundation also reports on research results in a timely manner to the medical community and interested advocacy organizations, aiming to improve early disease detection practices.
What are the reviews and ratings of this charity?
Charity Navigator Rating: Needs Improvement (Overall Score: 63%, Two-Star out of Four Star rating)
The Early Diagnosis and Treatment Research Foundation Inc has received a two-star rating from Charity Navigator, indicating that there are areas that require improvement. The organization has a strong program expense ratio of 76.04%, which suggests that a significant portion of its funding is directed towards its programs. Additionally, the foundation has a 100% independent board, which is a positive sign for governance and accountability.
However, the organization has notable gaps in its accountability and finance practices. Many critical policies, including conflict of interest, whistleblower, and document retention policies, are missing. Furthermore, essential documents, such as the website listing on the tax form and the tax form posted on the nonprofit's website, are also absent. These shortcomings have impacted its overall score, highlighting the need for better transparency and governance practices.
Overall, while the Early Diagnosis and Treatment Research Foundation Inc demonstrates commitment to its mission through program spending and an independent board, there are significant improvements needed in its operational policies and transparency to enhance its accountability to donors and stakeholders.
This AI summary has been generated from information found on Charity Navigator.
Is Early Diagnosis And Treatment Research Foundation Inc legitimate?
Early Diagnosis And Treatment Research Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Early Diagnosis And Treatment Research Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Early Diagnosis And Treatment Research Foundation Inc?
The Early Diagnosis and Treatment Research Foundation Inc's mission is centered around advancing research in the field of early diagnosis and treatment of diseases. Primarily, they focus on lung cancer, chronic obstructive pulmonary diseases (COPD), and cardiac diseases. They engage in continuous, active research to expand the knowledge base for early disease screening. The foundation holds conferences, conducts studies, and timely reports the results to the medical community and interested advocacy organizations. Their objective is to contribute significantly to the early detection and treatment of these diseases.
Who is the CEO of Early Diagnosis And Treatment Research Foundation Inc?
Claudia Henschke is the President, Treasurer of Early Diagnosis And Treatment Research Foundation Inc.
What is the revenue of Early Diagnosis And Treatment Research Foundation Inc?
Early Diagnosis And Treatment Research Foundation Inc's revenue in 2022 was $128,721.
Who are the executives of Early Diagnosis And Treatment Research Foundation Inc and what are their salaries?
Here are 2 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for Early Diagnosis And Treatment Research Foundation Inc?
Early Diagnosis And Treatment Research Foundation Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Mission Statement of Early Diagnosis And Treatment Research Foundation Inc
Early Diagnosis and Treatment Research Foundation Inc is dedicated to advancing and backing research in the domain of early diagnosis and treatment of diseases, with a primary focus on lung cancer, chronic obstructive pulmonary diseases, and cardiac diseases. The organization engages in continuous, active research to expand the knowledge base for the practice of screening for early diseases. They hold conferences, conduct studies, and promptly share the results with the medical community and interested advocacy organizations. The foundation's mission is to contribute to the early detection and treatment of diseases, ultimately improving healthcare outcomes.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Early Diagnosis and Treatment Research Foundation Inc plays a pivotal role in advancing medical knowledge and improving patient outcomes through dedicated research in early disease detection and treatment. By focusing on critical areas such as lung cancer, chronic obstructive pulmonary disease (COPD), and cardiac disease, the foundation actively contributes to a deeper understanding of these conditions, which can significantly enhance screening practices.
The foundation's impact is realized through continuous research efforts, including grants to other institutions and collaborative studies, which promote the sharing of knowledge and resources in the medical community. By organizing conferences and promptly reporting research findings, the foundation ensures that insights derived from its studies are disseminated widely, fostering collaboration among researchers and advocacy organizations. This collaborative environment accelerates innovation and the development of effective screening techniques, ultimately leading to earlier diagnoses and improved treatment strategies for patients in need.
This information is meant to be a general summary of Early Diagnosis And Treatment Research Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $80,899
- Gross Receipts: $460,426
Assets and Liabilities:
- Total Assets: $735,227
- Total Liabilities: $0
- Net Assets: $735,227
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2009
Principal Officer
Claudia Henschke
Main Address
178 COLUMBUS AVE 237119, NEW YORK, NY, 10023
NTEE Category
Code: H12 - Medical research
If you are a representative of Early Diagnosis And Treatment Research Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.